U.S. market Closed. Opens in 7 hours 44 minutes

PLRX | Pliant Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue1.58M9.69M7.57M41.82M57.05MN/AN/A
Cost of RevenueN/A3.68M3.20MN/AN/A666.00KN/A
Gross Profit1.58M6.00M4.37M41.82M57.05M-666.00KN/A
Operating Expenses185.72M136.88M27.56M83.46M58.28M30.91M18.35M
Selling, General & Admin57.93M39.95M27.56M17.27M10.93M6.50M3.82M
Research & Development127.80M96.94M77.55M66.19M47.35M24.41M14.53M
Other Operating ExpensesN/AN/A-77.55M-366.00K-216.00K-49.00KN/A
Operating Income-184.15M-127.20M-19.99M-41.65M-1.23M-30.91M-18.35M
Other Expenses / Income22.81M3.88M272.00K112.00K600.00K639.00K16.00K
Before Tax Income-161.34M-123.32M-19.71M-41.53M-631.00K-30.28M-18.33M
Income Tax ExpensesN/A-1.82M-1.81M-1.79M-816.00K639.00K2.29M
Net Income-161.34M-121.50M-17.91M-39.74M185.00K-30.28M-20.62M
Interest Expenses1.27M791.00K272.00K366.00K216.00KN/AN/A
Basic Shares Outstanding58.72M42.02M35.85M35.55M35.55M16.51M803.50K
Diluted Shares Outstanding58.72M42.02M35.85M35.55M35.55M16.51M803.50K
EBITDA-158.23M-118.85M-95.73M-40.34M-118.00K-30.25M-18.06M
EBITDA Margin-10,014.43%-1,227.15%-1,264.24%-96.46%-0.21%0.00%0.00%
EBIT-160.07M-122.53M-19.44M-41.17M-415.00K-29.64M-18.33M
EBIT Margin-10,130.95%-1,265.15%-256.76%-98.45%-0.73%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙